• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023

    8/21/23 5:30:10 PM ET
    $AKAN
    $BGXX
    $CGC
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $AKAN alert in real time by email

    GAINERS:

    • Radient Technologies (OTC:RDDTF) shares closed up 50.00% at $0.00
    • Trees (OTC:CANN) shares closed up 37.87% at $0.07
    • 1933 Industries (OTC:TGIFF) shares closed up 23.46% at $0.01
    • Malachite Innovations (OTC:MLCT) shares closed up 18.75% at $0.19
    • Nextleaf Solutions (OTC:OILFF) shares closed up 14.11% at $0.04
    • Item 9 Labs (OTC:INLB) shares closed up 13.33% at $0.02
    • BZAM (OTC:BZAMF) shares closed up 12.26% at $0.13
    • Leef Brands (OTC:LEEEF) shares closed up 11.80% at $0.02
    • CordovaCann (OTC:LVRLF) shares closed up 11.55% at $0.14
    • Willow Biosciences (OTC:CANSF) shares closed up 9.55% at $0.06
    • CLS Holdings USA (OTC:CLSH) shares closed up 9.22% at $0.07
    • Intercure (NASDAQ:INCR) shares closed up 9.15% at $1.55
    • SLANG Worldwide (OTC:SLGWF) shares closed up 8.72% at $0.03
    • Decibel Cannabis Co (OTC:DBCCF) shares closed up 7.90% at $0.11
    • Enveric Biosciences (NASDAQ:ENVB) shares closed up 7.44% at $2.31
    • Vext Science (OTC:VEXTF) shares closed up 6.90% at $0.17
    • CV Sciences (OTC:CVSI) shares closed up 6.76% at $0.04
    • Stem Holdings (OTC:STMH) shares closed up 6.31% at $0.01
    • SciSparc (NASDAQ:SPRC) shares closed up 5.18% at $0.18
    • MariMed (OTC:MRMD) shares closed up 5.12% at $0.30
    • InnoCan Pharma (OTC:INNPF) shares closed up 4.59% at $0.20
    • Curaleaf Holdings (OTC:CURLF) shares closed up 4.30% at $2.91
    • Flora Growth (NASDAQ:FLGC) shares closed up 4.27% at $2.20
    • Livewire Ergogenics (OTC:LVVV) shares closed up 4.22% at $0.00
    • Entourage Health (OTC:ETRGF) shares closed up 3.84% at $0.01
    • Incannex Healthcare (NASDAQ:IXHL) shares closed up 3.79% at $1.50
    • C21 Investments (OTC:CXXIF) shares closed up 3.32% at $0.25
    • Elixinol Wellness (OTC:ELLXF) shares closed up 3.12% at $0.01

    LOSERS:

    • Red White & Bloom Brands (OTC:RWBYF) shares closed down 87.28% at $0.01
    • CBD Of Denver (OTC:CBDD) shares closed down 33.33% at $0.00
    • Tetra Bio Pharma (OTC:TBPMF) shares closed down 31.25% at $0.00
    • 1606 (OTC:CBDW) shares closed down 25.00% at $0.03
    • Heritage Cannabis Holding (OTC:HERTF) shares closed down 18.48% at $0.01
    • Kaya Holdings (OTC:KAYS) shares closed down 18.33% at $0.04
    • Skye Bioscience (OTC:SKYE) shares closed down 15.14% at $0.01
    • Leafbuyer Techs (OTC:LBUY) shares closed down 12.92% at $0.06
    • Auxly Cannabis Group (OTC:CBWTF) shares closed down 12.31% at $0.01
    • Bright Green (NASDAQ:BGXX) shares closed down 12.27% at $0.58
    • StateHouse Hldgs (OTC:STHZF) shares closed down 11.62% at $0.02
    • Body and Mind (OTC:BMMJ) shares closed down 11.25% at $0.05
    • Canopy Gwth (NASDAQ:CGC) shares closed down 10.18% at $0.41
    • SNDL (NASDAQ:SNDL) shares closed down 9.39% at $1.64
    • Rocky Mountain High (OTC:RMHB) shares closed down 9.09% at $0.01
    • TILT Holdings (OTC:TLLTF) shares closed down 8.03% at $0.03
    • Grown Rogue International (OTC:GRUSF) shares closed down 7.74% at $0.18
    • cbdMD (AMEX:YCBD) shares closed down 7.56% at $1.10
    • 4Front Ventures (OTC:FFNTF) shares closed down 7.32% at $0.10
    • CNBX Pharmaceuticals (OTC:CNBX) shares closed down 7.27% at $0.01
    • Medicine Man Technologies (OTC:SHWZ) shares closed down 6.43% at $0.71
    • Tilray Brands (NASDAQ:TLRY) shares closed down 5.68% at $2.49
    • SHF Hldgs (NASDAQ:SHFS) shares closed down 5.64% at $0.42
    • Chicago Atlantic Real (NASDAQ:REFI) shares closed down 5.59% at $14.18
    • Cansortium (OTC:CNTMF) shares closed down 5.22% at $0.07
    • Charlottes Web Holdings (OTC:CWBHF) shares closed down 5.14% at $0.21
    • OrganiGram Holdings (NASDAQ:OGI) shares closed down 5.10% at $1.49
    • Acreage Holdings (OTC:ACRHF) shares closed down 4.92% at $0.14
    • Indiva (OTC:NDVAF) shares closed down 4.85% at $0.02
    • MGC Pharmaceuticals (OTC:MGCLF) shares closed down 4.35% at $0.00
    • Cannara Biotech (OTC:LOVFF) shares closed down 4.29% at $0.78
    • Akanda (NASDAQ:AKAN) shares closed down 4.22% at $0.46
    • Leafly Holdings (NASDAQ:LFLY) shares closed down 4.04% at $0.33
    • Zynerba Pharmaceuticals (NASDAQ:ZYNE) shares closed down 3.79% at $1.27
    • Cronos Group (NASDAQ:CRON) shares closed down 3.76% at $1.79
    • Ayr Wellness (OTC:AYRWF) shares closed down 3.49% at $0.82
    • Acreage Holdings (OTC:ACRDF) shares closed down 3.46% at $0.22
    • Unrivaled Brands (OTC:UNRV) shares closed down 3.16% at $0.02
    • Urban-gro (NASDAQ:UGRO) shares closed down 3.12% at $1.11

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $AKAN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKAN
    $BGXX
    $CGC
    $CRON

    CompanyDatePrice TargetRatingAnalyst
    Tilray Brands Inc.
    $TLRY
    1/27/2026Hold
    Canaccord Genuity
    Organigram Global Inc.
    $OGI
    1/27/2026Buy
    Canaccord Genuity
    Cronos Group Inc.
    $CRON
    1/27/2026Buy
    Canaccord Genuity
    Canopy Growth Corporation
    $CGC
    11/10/2025Sell → Hold
    The Benchmark Company
    SNDL Inc.
    $SNDL
    9/3/2025$5.00Buy
    Alliance Global Partners
    Chicago Atlantic Real Estate Finance Inc.
    $REFI
    12/17/2024$20.00Buy
    Alliance Global Partners
    Flora Growth Corp.
    $FLGC
    11/25/2024$4.00Buy
    Aegis Capital
    SNDL Inc.
    $SNDL
    7/17/2024Speculative Buy
    Canaccord Genuity
    More analyst ratings

    $AKAN
    $BGXX
    $CGC
    $CRON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SNDL to Report Fourth Quarter 2025 and Full Year 2025 Financial Results on March 12, 2026

    EDMONTON, Alberta, Feb. 19, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ:SNDL, CSE:SNDL) ("SNDL") announced today that it will release its fourth quarter and full year 2025 financial results for the period ended December 31, 2025, before markets open on Thursday, March 12, 2026. Following the release of its fourth quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on March 12, 2026. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/aps8jm4e ABOUT SNDL INC.  SNDL Inc. (NASDAQ:SNDL, CSE:SNDL), through its wholly owned subsidiaries, is one of the largest vertically integr

    2/19/26 4:30:00 PM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

    Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data

    Proprietary assays demonstrate dual Gq and β-arrestin signaling at 5-HT₂A, pathways linked in peer-reviewed studies to antidepressant and anxiolytic effects A recent independent Nature study reports that distinct signaling pathways support mechanistic separation of therapeutic benefit from hallucinations Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced new mechanistic data demonstrating that its lead candidate, EB-003, activates both Gq- and β-arrestin–mediated signaling downstream of the 5-HT₂A receptor. Multiple independ

    2/19/26 8:00:00 AM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million

    InterCure reports preliminary estimated revenue of NIS 265 million for 2025 and positive Adjusted EBITDA2, marking its twelfth consecutive half-year of positive Adjusted EBITDA. Revenue for 2025 represents an increase of approximately 11% compared to 2024, while revenue for the second half of 2025 is nearly 20% higher than the corresponding period in the prior year. During the second half of 2025, the Company generated its first significant revenues from the German market. NEW YORK and HERZLIYA, Israel, Feb. 19, 2026 (GLOBE NEWSWIRE) -- InterCure Ltd. (Nasdaq: INCR) (TASE: INCR) ("InterCure" or the "Company") today announced preliminary results for the full year of 2025. All amounts ar

    2/19/26 7:00:00 AM ET
    $INCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKAN
    $BGXX
    $CGC
    $CRON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Mongeau Luc sold $9,951 worth of shares (9,376 units at $1.06), decreasing direct ownership by 1% to 802,992 units (SEC Form 4)

    4 - Canopy Growth Corp (0001737927) (Issuer)

    2/12/26 7:53:43 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Large owner Hrt Financial Lp bought $40,650 worth of Class A Shares (29,036 units at $1.40) and sold $10,150 worth of Class A Shares (7,868 units at $1.29) (SEC Form 4)

    4 - AKANDA CORP. (0001888014) (Issuer)

    1/20/26 2:07:19 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    New insider Hrt Financial Lp claimed ownership of 15,684 units of Class A Shares (SEC Form 3)

    3 - AKANDA CORP. (0001888014) (Issuer)

    1/20/26 1:36:34 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    $AKAN
    $BGXX
    $CGC
    $CRON
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hrt Financial Lp bought $40,650 worth of Class A Shares (29,036 units at $1.40) and sold $10,150 worth of Class A Shares (7,868 units at $1.29) (SEC Form 4)

    4 - AKANDA CORP. (0001888014) (Issuer)

    1/20/26 2:07:19 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Papastavrou Jason D bought $227,740 worth of shares (18,000 units at $12.65), increasing direct ownership by 25% to 49,546 units (SEC Form 4)

    4 - Chicago Atlantic Real Estate Finance, Inc. (0001867949) (Issuer)

    10/16/25 6:11:09 PM ET
    $REFI
    Real Estate Investment Trusts
    Real Estate

    Chief Operating Officer Kite David bought $62,525 worth of shares (5,000 units at $12.51), increasing direct ownership by 9% to 59,516 units (SEC Form 4)

    4 - Chicago Atlantic Real Estate Finance, Inc. (0001867949) (Issuer)

    10/16/25 5:26:59 PM ET
    $REFI
    Real Estate Investment Trusts
    Real Estate

    $AKAN
    $BGXX
    $CGC
    $CRON
    SEC Filings

    View All

    urban-gro Inc. filed SEC Form 8-K: Leadership Update

    8-K - urban-gro, Inc. (0001706524) (Filer)

    2/19/26 4:58:18 PM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    SEC Form 6-K filed by SNDL Inc.

    6-K - SNDL Inc. (0001766600) (Filer)

    2/19/26 4:40:03 PM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Organigram Global Inc.

    6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)

    2/19/26 2:21:54 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKAN
    $BGXX
    $CGC
    $CRON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Tilray

    Canaccord Genuity initiated coverage of Tilray with a rating of Hold

    1/27/26 9:29:20 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Canaccord Genuity initiated coverage on Organigram Global

    Canaccord Genuity initiated coverage of Organigram Global with a rating of Buy

    1/27/26 9:29:20 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canaccord Genuity initiated coverage on Cronos Group

    Canaccord Genuity initiated coverage of Cronos Group with a rating of Buy

    1/27/26 9:29:20 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    $AKAN
    $BGXX
    $CGC
    $CRON
    Leadership Updates

    Live Leadership Updates

    View All

    Breckenridge Distillery Appoints Romano Beverage for Distribution in Illinois

    BRECKENRIDGE, Colo., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand owned by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), has announced appointment of Romano Beverage, a respected partner, to manage distribution responsibilities within the state. Romano Beverage, a trusted leader in beverage distribution, is now overseeing Breckenridge Distillery's full spirits collection across Illinois—including its celebrated bourbon whiskey, whiskey, rum, vodka, gin, and newly launched Mountain Shot. Romano's strong presence in Illinois and dedication to exceptional service make them the perfect partner to help Breckenridge Distillery thr

    2/4/26 8:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Incannex Healthcare Announces Additional Appointments to Clinical Advisory Board

    MELBOURNE, Australia and NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (NASDAQ:IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced the appointment of three additional members to its recently established Clinical Advisory Board ("CAB"): Murray B. Stein, MD, MPH; Andrew Cutler, MD; and Amir Kalali, MD. The CAB was formed to provide independent clinical and scientific guidance as the Company progresses PSX-001 into its next phase of clinical and regulatory development. The addition of Drs. Stein, Cutler, and Kalali further strengthens the Board's expertise across psychiatry, neurobiology, psychopharmacology, an

    1/29/26 8:00:00 AM ET
    $IXHL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Safe Harbor Bolsters Lending Capabilities and Client Experience with Strategic Leadership Hires

    DENVER, Dec. 30, 2025 (GLOBE NEWSWIRE) -- SHF Holdings, Inc., d/b/a Safe Harbor (the "Company") (NASDAQ:SHFS), a fintech leader in providing banking, lending and financial services to the regulated cannabis and hemp industries, announced the addition of two key executives to its leadership team. Stephen La Rosa joins Safe Harbor as Senior Vice President, Lending Strategy and Partner Development and Cassandra Douglas as Senior Manager Client Experience and Onboarding. These hires represent a proactive investment in the people and capabilities required to support cannabis operators across their full financial lifecycle — from onboarding and compliance to capital access and long-term growth.

    12/30/25 8:00:00 AM ET
    $SHFS
    Finance: Consumer Services
    Finance

    $AKAN
    $BGXX
    $CGC
    $CRON
    Financials

    Live finance-specific insights

    View All

    SNDL to Report Fourth Quarter 2025 and Full Year 2025 Financial Results on March 12, 2026

    EDMONTON, Alberta, Feb. 19, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ:SNDL, CSE:SNDL) ("SNDL") announced today that it will release its fourth quarter and full year 2025 financial results for the period ended December 31, 2025, before markets open on Thursday, March 12, 2026. Following the release of its fourth quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on March 12, 2026. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/aps8jm4e ABOUT SNDL INC.  SNDL Inc. (NASDAQ:SNDL, CSE:SNDL), through its wholly owned subsidiaries, is one of the largest vertically integr

    2/19/26 4:30:00 PM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

    Chicago Atlantic Real Estate Finance Schedules Fourth Quarter 2025 Earnings Release and Conference Call Date

    CHICAGO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI) ("Chicago Atlantic" or the "Company"), a commercial mortgage real estate investment trust, announced details for the release of its results for the fourth quarter and year ended December 31, 2025. The Company plans to issue its earnings release and supplemental financial information before the market opens on Thursday, March 12, 2026. Chicago Atlantic will host a conference call and live audio webcast, both open for the general public to hear, later that day at 9:00 a.m. Eastern Time. The number to call for this interactive teleconference is (833) 630-1956 (international callers: 412-317-18

    2/18/26 7:00:00 AM ET
    $REFI
    Real Estate Investment Trusts
    Real Estate

    cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

    CHARLOTTE, N.C., Feb. 17, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD, Bluebird Botanicals, Paw CBD, along with its THC beverage brand Oasis today announced its financial results for the first quarter of fiscal year ended December 31, 2025. cbdMD reported 12% sequential revenue growth and improved liquidity in the first quarter of fiscal 2026, reflecting continued stabilization of the core business and early benefits from recent strategic actions."We a

    2/17/26 4:10:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    $AKAN
    $BGXX
    $CGC
    $CRON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:02:53 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:01:40 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKAN
    $BGXX
    $CGC
    $CRON
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary